nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge
|
Fekadu, M. |
|
1992 |
10 |
3 |
p. 192-197 6 p. |
artikel |
2 |
A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens
|
Harabacz, I. |
|
1992 |
10 |
3 |
p. 145-150 6 p. |
artikel |
3 |
Auxotrophic live oral Shigella flexneri vaccine protects monkeys against challenge with S. flexneri of different serotypes
|
Kärnell, Anders |
|
1992 |
10 |
3 |
p. 167-174 8 p. |
artikel |
4 |
Calendar
|
|
|
1992 |
10 |
3 |
p. 200- 1 p. |
artikel |
5 |
Carrier-bound recombinant proteins for vaccine against HIV virus, hepatitis B virus, Epstein-Barr virus, etc.; expression of gene fusion encoding recombinant protein-phage non-lytic membrane integrating protein domain, and phage lytic membrane protein or toxin release gene in Gram-negative bacterium
|
|
|
1992 |
10 |
3 |
p. 198- 1 p. |
artikel |
6 |
Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production
|
Phillips, Nigel C. |
|
1992 |
10 |
3 |
p. 151-158 8 p. |
artikel |
7 |
Feline infectious-peritonitis virus vaccine; produced by serial passage in non-oncogenic e.g. FCWF, CrFK cell culture
|
|
|
1992 |
10 |
3 |
p. 198-199 2 p. |
artikel |
8 |
Murine cross-reactive T-cell epitopes of Neisseria meningitidis outer membrane proteins
|
Lifely, M.Robert |
|
1992 |
10 |
3 |
p. 159-163 5 p. |
artikel |
9 |
New glutathione-S-transferase of Schistosoma mansoni; DNA sequence; site-directed mutagenesis and expression in Escherichia coli for use as recombinant vaccine or in therapy of schistosomiasis
|
|
|
1992 |
10 |
3 |
p. 199- 1 p. |
artikel |
10 |
New HTLV-I virus env recombinant protein; expression in Escherichia coli using vector plasmid pT7-785; potential application in recombinant vaccine and diagnosis of HTLV-I virus infection
|
|
|
1992 |
10 |
3 |
p. 198- 1 p. |
artikel |
11 |
New recombinant herpes virus e.g. turkey herpes virus; encoding viral, bacterial or parasitic immunogen; application as multivalent live recombinant vaccine vector
|
|
|
1992 |
10 |
3 |
p. 198- 1 p. |
artikel |
12 |
Peptide corresponding to poliovirus VP1 antigen; used in vaccine or diagnosis of disease caused by enterovirus; preparation by chemical or recombinant DNA methods; RNA sequence
|
|
|
1992 |
10 |
3 |
p. 198- 1 p. |
artikel |
13 |
Plasmodium Duffy receptor protein; Plasmodium knowlesi or Plasmodium vivax gene cloning and expression; potential recombinant vaccine against malaria; DNA sequence
|
|
|
1992 |
10 |
3 |
p. 199- 1 p. |
artikel |
14 |
Potency testing of acellular pertussis vaccines
|
Robinson, A. |
|
1992 |
10 |
3 |
p. 139-141 3 p. |
artikel |
15 |
Protecting against Bordetella pertussis or Bordetella bronchiseptica using native, recombinant vaccine consisting of 69 kDa outer membrane protein or filamentous hemagglutinin protein purified from B. pertussis, Bordetella parapertussis or B. bronchiseptica
|
|
|
1992 |
10 |
3 |
p. 199- 1 p. |
artikel |
16 |
Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance
|
Storsaeter, Jann |
|
1992 |
10 |
3 |
p. 142-144 3 p. |
artikel |
17 |
Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1–14 years
|
Patarroyo, Gloria |
|
1992 |
10 |
3 |
p. 175-178 4 p. |
artikel |
18 |
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity
|
Amador, Roberto |
|
1992 |
10 |
3 |
p. 179-184 6 p. |
artikel |
19 |
Use of BHK cell culture-adapted Newcastle disease virus for immunization of chicks
|
Reddy, G.S. |
|
1992 |
10 |
3 |
p. 164-166 3 p. |
artikel |
20 |
Vaccinia—rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea
|
Andrew, Marion E. |
|
1992 |
10 |
3 |
p. 185-191 7 p. |
artikel |